There were more than 10 times as many proven infections and almost 20 times as many severe illnesses among people with two jabs than among people who had received a third shot
The vaccine is "highly effective" in preventing coronavirus infections, says a draft of the study, conducted by Pfizer and BioNTech together with the Israeli Health Ministry.
EU states are hoping that vaccinating enough of the population will ensure herd immunity, though the exact target rate differs from country to country. For example, France is aiming for 60%, and…
The go-ahead from the Medicines and Healthcare products Regulatory Agency (MHRA) paves the way for Pfizer and BioNTech to begin delivering doses "immediately" to the country.
This puts the companies neck and neck with US firm Moderna, which also applied to the EU regulator for the conditional approval of its Covid-19 vaccine on Monday.
US pharmaceuticals giant Pfizer and its German partner BioNTech have announced that their drug is 95% effective, and that there were no safety concerns.